LC3A Cancer Research Results
LC3A, Microtubule-associated protein 1 light chain 3 alpha: Click to Expand ⟱
| Source: |
| Type: |
LC3A is one of the isoforms of the LC3 family and plays a critical role in the autophagy pathway.
– Enhanced Autophagy and Tumor Survival: In some cancers, increased LC3A expression (and therefore autophagic activity) is associated with a cytoprotective response, helping tumor cells survive under stress conditions such as hypoxia, nutrient deprivation, or treatment-induced damage. This has been linked in some cases to more aggressive tumor behavior and resistance to therapies.
|
Scientific Papers found: Click to Expand⟱
CDK1↓, graphical abstract
Cyc↓,
p27↑,
P21↑,
P53↑,
TumCCA↑, Cell cycle arrest
TumCI↓, Inhibit invastion
MMP2↓,
MMP9↓,
E-cadherin↑,
N-cadherin↓,
Vim↓,
LC3A↑,
p62↓,
p‑mTOR↓,
PD-L1↓,
CAFs/TAFs↓,
VEGF↓,
ROCK1↓,
Bcl-2↓,
Bcl-xL↓,
BAX↑,
ROS↑,
cl‑PARP↑,
Casp3↑,
Casp9↑,
PTEN↑, A549, H460
MMP↓, ↓mitochondrial transmembrane potential, redistribution of cytochrome c,
Cyt‑c↑,
Ca+2↑, ↑Ca2+
PERK↑, ↑PERK, ↑IRE1α, ↑CHOP,
IRE1↑,
CHOP↑,
Copper↑, ↑Cu+2
Snail↓, ↓Snail, ↓vimentin, ↓Twist1,
Vim↓,
Twist↓,
GSH↓, ↑ROS, ↓GSH, ↑MDA, ↓MMP, ↓NRF2, ↓HO-1, ↓GPX4, ↓FTH1, ↑TFR1, ↓p-JAK2, ↓p-STAT3
NRF2↓,
HO-1↓,
GPx4↓,
XIAP↓, ↓Bcl-2, ↓Bcl-xL, ↓XIAP, ↓surviving
survivin↓,
DR5↑, ↑ROS, ↑DR5
*Bcl-2↓, Vitamin K2 played a significant part in apoptosis by upregulating and downregulating Bcl-2 and Bax protein expressions, respectively, which inhibited mitochondrial depolarization, and ROS accumulation to maintain mitochondrial structure and function
*BAX↑,
*MMP↑, vitamin K2 can restore the mitochondrial membrane potential and inhibit mitochondrial depolarization caused by 6-OHDA.
*ROS↓, vitamin K2 can effectively remove the ROS generated by 6-OHDA and relieve cellular oxidative stress.
*p62↓, vitamin K2 treatments downregulated the expression level of p62 and upregulated the expression level of LC3A
*LC3A↑,
*Dose↝, vitamin K2 inhibited the toxic effect of 6-OHDA, and that the inhibitory effect was the best at a concentration of 30 µM
*Apoptosis↓, However, after vitamin K2 post-treatment, the apoptosis rate was significantly reduced to 11.44%.
*PINK1↑, Vitamin K2 Regulates Mitochondrial Quality-Control System by Activating Pink1/Parkin Signaling Pathway
*PARK2↑,
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
Copper↑, 1, GPx4↓, 1, GSH↓, 1, HO-1↓, 1, NRF2↓, 1, ROS↑, 1,
Mitochondria & Bioenergetics ⓘ
MMP↓, 1, XIAP↓, 1,
Cell Death ⓘ
BAX↑, 1, Bcl-2↓, 1, Bcl-xL↓, 1, Casp3↑, 1, Casp9↑, 1, Cyt‑c↑, 1, DR5↑, 1, p27↑, 1, survivin↓, 1,
Protein Folding & ER Stress ⓘ
CHOP↑, 1, IRE1↑, 1, PERK↑, 1,
Autophagy & Lysosomes ⓘ
LC3A↑, 1, p62↓, 1,
DNA Damage & Repair ⓘ
P53↑, 1, cl‑PARP↑, 1,
Cell Cycle & Senescence ⓘ
CDK1↓, 1, Cyc↓, 1, P21↑, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
p‑mTOR↓, 1, PTEN↑, 1,
Migration ⓘ
Ca+2↑, 1, CAFs/TAFs↓, 1, E-cadherin↑, 1, MMP2↓, 1, MMP9↓, 1, N-cadherin↓, 1, ROCK1↓, 1, Snail↓, 1, TumCI↓, 1, Twist↓, 1, Vim↓, 2,
Angiogenesis & Vasculature ⓘ
VEGF↓, 1,
Immune & Inflammatory Signaling ⓘ
PD-L1↓, 1,
Clinical Biomarkers ⓘ
PD-L1↓, 1,
Total Targets: 44
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
PARK2↑, 1, ROS↓, 1,
Mitochondria & Bioenergetics ⓘ
MMP↑, 1, PINK1↑, 1,
Cell Death ⓘ
Apoptosis↓, 1, BAX↑, 1, Bcl-2↓, 1,
Autophagy & Lysosomes ⓘ
LC3A↑, 1, p62↓, 1,
Drug Metabolism & Resistance ⓘ
Dose↝, 1,
Total Targets: 10
Scientific Paper Hit Count for: LC3A, Microtubule-associated protein 1 light chain 3 alpha
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1282 State#:% Dir#:2
wNotes=on sortOrder:rid,rpid
Home Page